PMS17 COST EFFECTIVENESS ANALYSIS OF UPADACITINIB AND METHOTREXATE FOR PATIENTS WITH METHOTREXATE-RESISTANT RHEUMATOID ARTHRITIS
May 1, 2020, 00:00
10.1016/j.jval.2020.04.704
https://www.valueinhealthjournal.com/article/S1098-3015(20)30892-5/fulltext
Title :
PMS17 COST EFFECTIVENESS ANALYSIS OF UPADACITINIB AND METHOTREXATE FOR PATIENTS WITH METHOTREXATE-RESISTANT RHEUMATOID ARTHRITIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30892-5&doi=10.1016/j.jval.2020.04.704
First page :
Section Title :
Open access? :
No
Section Order :
10597